| Revision as of 12:39, 6 December 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 458527602 of page Regavirumab for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Latest revision as of 20:46, 1 December 2023 edit Buidhe (talk | contribs)Autopatrolled, Extended confirmed users, Page movers, File movers, Mass message senders, New page reviewers, Pending changes reviewers, Template editors136,073 editsm Moving from Category:Experimental drugs to Category:Experimental monoclonal antibodies using Cat-a-lot |
| Line 1: |
Line 1: |
|
⚫ |
{{Short description|Monoclonal antibody}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{Drugbox |
|
{{Drugbox |
|
| Verifiedfields = changed |
|
| Verifiedfields = changed |
|
| verifiedrevid = 458438680 |
|
| verifiedrevid = 464380525 |
|
| image = |
|
| image = |
|
|
<!-- Monoclonal antibody data --> |
|
|
|
| ⚫ |
<!--Monoclonal antibody data--> |
|
|
| type = mab |
|
| type = mab |
|
| mab_type = mab |
|
| mab_type = mab |
|
| source = u |
|
| source = u |
|
| target = ] glycoprotein B |
|
| target = ] glycoprotein B |
|
⚫ |
<!-- Clinical data --> |
|
|
|
| ⚫ |
<!--Clinical data--> |
|
|
| tradename = |
|
| tradename = |
|
| pregnancy_AU = |
|
| pregnancy_AU = |
| Line 22: |
Line 20: |
|
| legal_status = |
|
| legal_status = |
|
| routes_of_administration = |
|
| routes_of_administration = |
|
⚫ |
<!-- Pharmacokinetic data --> |
|
|
|
| ⚫ |
<!--Pharmacokinetic data--> |
|
|
| bioavailability = |
|
| bioavailability = |
|
| protein_bound = |
|
| protein_bound = |
| Line 29: |
Line 26: |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
⚫ |
<!-- Identifiers --> |
|
|
|
|
⚫ |
| CAS_number_Ref = {{cascite|correct|CAS}} |
| ⚫ |
<!--Identifiers--> |
|
|
⚫ |
| CAS_number = 153101-26-9 |
| ⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
| ⚫ |
| ChemSpiderID = NA |
|
|
|
| UNII = STG2Q92FWF |
| ⚫ |
| CAS_number_Ref = {{cascite|changed|??}} |
|
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
| ⚫ |
| CAS_number = <!-- blanked - oldvalue: 153101-26-9 --> |
|
|
⚫ |
| ChemSpiderID = none |
|
| ATC_prefix = none |
|
| ATC_prefix = none |
|
| ATC_suffix = |
|
| ATC_suffix = |
| Line 40: |
Line 38: |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank = |
|
| DrugBank = |
|
|
| KEGG = D09852 |
|
|
|
|
<!--Chemical data--> |
|
<!-- Chemical data --> |
|
| chemical_formula = |
|
| chemical_formula = |
|
| molecular_weight = |
|
| molecular_weight = |
|
}} |
|
}} |
|
|
|
|
|
'''Regavirumab''' is a ] ] against infections with ].<ref>{{cite journal | vauthors = Arizono H, Sugano T, Kaida S, Shibusawa K, Karasawa Y, Esumi Y, Kondo S, Kiyoki M | display-authors = 6 | title = Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys | journal = Arzneimittel-Forschung | volume = 44 | issue = 7 | pages = 909–13 | date = July 1994 | pmid = 7945531 }}</ref> |
|
|
|
|
|
== References == |
|
|
{{reflist}} |
|
|
|
|
|
{{Monoclonals for infectious disease and toxins}} |
|
|
|
|
|
] |
|
|
] |
|
|
] |
|
|
{{antiinfective-drug-stub}} |
|
|
{{monoclonal-antibody-stub}} |